title: Author reply: To PMID 24576886.
authors.affiliation: Research Institute of Ophthalmology, Cairo, Egypt.
authors.forename: Dalia G
authors.initials: DG
authors.lastname: Said
authors.affiliation: Division of Ophthalmology, Department of Clinical Neurosciences, Geneva University Hospitals, Geneva, Switzerland.
authors.forename: Zisis
authors.initials: Z
authors.lastname: Gatzioufas
authors.affiliation: Division of Ophthalmology, Department of Clinical Neurosciences, Geneva University Hospitals, Geneva, Switzerland; Department of Ophthalmology, Keck School of Medicine, University of Southern California, Los Angeles, California States.
authors.forename: Farhad
authors.initials: F
authors.lastname: Hafezi
mesh_terms: D003094:Collagen / Q000378:metabolism*; D003320:Corneal Ulcer / Q000188:drug therapy*; D003432:Cross-Linking Reagents / Q000627:therapeutic use*; D015817:Eye Infections / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D017319:Photosensitizing Agents / Q000627:therapeutic use*; D012256:Riboflavin / Q000627:therapeutic use*
chemical_list: D003432:Cross-Linking Reagents; D017319:Photosensitizing Agents; D003094:Collagen; D012256:Riboflavin